SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The index is trending due to rising concerns over surging Treasury yields, high oil prices, and industry-wide uncertainty regarding the pace of AI development. Traders are debating the likelihood of a Federal Reserve rate hike while closely watching economic indicators and geopolitical tensions.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The conversation is dominated by concerns over rising Treasury yields, which briefly topped 5%, alongside ongoing uncertainty regarding AI-sector development and expectations for a Federal Reserve rate hike. Market participants are debating whether current volatility represents a cooling phase or a potential crash, with a notable split between those reacting to macro headwinds and those betting on a continued market recovery.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as traders speculate on positive guidance updates and clinical progress, following recent healthcare conference appearances and anticipation of upcoming Phase 2 NSCLC trial data. While the stock has seen significant momentum, community sentiment remains focused on the expectation that the company's solid tumor platform and clinical milestones will drive long-term value.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin shares are facing significant volatility as traders debate whether the stock is being manipulated by institutional accumulation or if macroeconomic headwinds and analyst price target downgrades are suppressing the price. The community remains divided, with many bullish investors holding for a recovery toward previous highs, while others express frustration over the stock's inability to maintain gains despite strong fundamentals and cash flow.

ProShares Trust II - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

Traders are actively debating the viability of using UVXY as a volatility hedge amidst geopolitical tensions and economic concerns, with many expressing frustration over its structural decay and perceived lack of correlation to spot VIX. While some market participants are betting on a volatility spike, others warn that its design as a leveraged futures-based product makes it a poor long-term holding prone to constant value erosion.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne shares are trending as investors weigh strong institutional accumulation and growth potential in the AI-driven cybersecurity sector against mixed fiscal second-quarter results. While analysts remain divided over valuation and the pace of profitability, the community is largely focused on the stock's discounted valuation relative to peers and the ongoing speculation regarding a potential acquisition by a major technology firm.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The IWM is experiencing downward pressure as traders remain concerned about rising oil prices and Treasury yields ahead of upcoming inflation data and a potential Federal Reserve rate hike. The conversation is fragmented, with many traders focused on technical indicators and Elliott Wave analysis suggesting a corrective decline, while others are debating the potential market impact of macroeconomic and geopolitical instability.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech shares are experiencing volatility following a weak revenue outlook and the announcement that its co-founders will depart by year-end to launch a separate mRNA venture. While some investors express concern over the leadership transition, others remain bullish, citing the company's substantial cash position and its late-stage oncology pipeline as significant long-term catalysts.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is trending as investors discuss a newly announced partnership with Supermicro to integrate high-density rack-scale servers into the company's Secure AI Factory platform. While some traders are optimistic about the potential for enterprise AI growth, many others remain frustrated by the stock's recent stagnant price action and weak momentum following its earnings report.

Quantinuum Inc. is a quantum computing platform that offers solutions like hardware platforms, developer tools, application libraries and solution-targeted intellectual property (“IP”). The company was founded on January 20, 2026 and is headquartered in Broomfield, CO.

Quantinuum Inc. - Ordinary Shares - Class A

Quantinuum Inc.

Quantinuum is trending following its recent NASDAQ IPO and a new strategic partnership with Oracle to deploy its Helios quantum technology, though community sentiment is divided between optimism regarding its institutional backing and concerns over high valuation relative to current revenue. Traders are also actively discussing the broader quantum sector, fueled by recent U.S. government policy initiatives and federal funding awards for key industry players.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ACA, APGE, BOLD, and GBCS

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ACA, APGE, BOLD, and GBCS SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ACA, APGE, BOLD, and GBCS PR Newswire NEW YORK, July 2, 2026 NEW YORK, July 2, 2026 /PRNewswire/ -- Class...

Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders?

Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 25, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

Why Did BOLD, BLZE, QNT Stocks Surge To 52-Week Highs Today 

Equity

Investors showed interest in businesses tied to artificial intelligence infrastructure, advanced biotechnology, and quantum computing.



$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Boundless Bio, Inc. (NASDAQ: BOLD)

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Boundless Bio, Inc. (NASDAQ: BOLD) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Boundless Bio, Inc. (NASDAQ: BOLD) PR Newswire NEW YORK, June 23, 2026 NEW YORK, June 23, 2026 /PRNewswire...

BOLD Stock Is Up 90% — Here's What's Behind The Biggest Rally In Company History

Boundless Bio is set to merge with Serapha Bio, with the transaction set to close in the fourth quarter of 2026.

BOLD Stock Alert: Halper Sadeh LLC is Investigating Whether Boundless Bio, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Boundless Bio, Inc. (NASDAQ: BOLD) and Serapha Bio, Inc. Upon closing of the proposed transaction, Boundless Bio shareholders are expected to own approximately 3.7% of the combined company.Halper Sadeh encourages...

Market Movers Catching Transformational Catalysts

Today’s common theme is scale. Whether through regulatory advancement, access to new capital, expanding commercial opportunities, or technological innovation, companies that successfully execute during periods of rapid change often find themselves at important inflection points. $NTHI, $BOLD, $BLZE, $CRWV, $PLTR, $ZETA, $ATLN, $HSCS

Big Money Backs Base Editing, as BOLD Deal Creates Well-Funded AATD Contender

The biotechnology sector continues to reward companies developing potentially transformative genetic medicines, particularly those addressing serious diseases with limited treatment options. The latest example emerged as Boundless Bio (NASDAQ:BOLD) announced a merger agreement with privately held Serapha Bio, a clinical-stage gene editing company developing an investigational treatment for Alpha-1 Antitrypsin Deficiency (AATD), alongside a substantial $230 million private financing commitment from a syndicate of prominent healthcare investors.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers

HeartSciences (NASDAQ:HSCS) stock rose 82.2% to $3.23 during Tuesday's pre-market session. The company's market cap stands at $5.6 million.
Boundless Bio (NASDAQ:BOLD) shares rose 62.85% to $2.28. Theread more...

Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034)  DelveInsight

Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight Biliary Tract Cancer Market is Predicted to Exhibit...

Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in La Jolla, CA.

Boundless Bio Inc.

Bullish Sentiment

50bps hike

25bps hike

No change

25bps cut

The Federal Reserve's September FOMC meeting concludes Wednesday, September 16, with a rate decision due at 2:00 PM ET, following Tuesday's CPI report that showed inflation still running above the Fed's 2% target. What do you think the Fed decides at this week's FOMC meeting? Vote and explain your reasoning in the comments.

The Fed&#39;s rate decision comes Wednesday at 2PM ET. What do you think happens?

Stocktwits

The Fed's rate decision comes Wednesday at 2PM ET. What do you think happens?

Feed

News

Sentiment

Earnings

Fundamentals

Info

BOLD Boundless Bio Inc.

Fundamentals

Latest BOLD News